The <i>Pros</i> and <i>Cons</i> of Cystic Fibrosis (CF) Patient Use of Herbal Supplements Containing <i>Pulmonaria officinalis</i> L. Extract: the Evidence from an In Vitro Study on <i>Staphylococcus aureus</i> CF Clinical Isolates
The justification for the use of herbal supplements with <i>Pulmonaria officinalis</i> L. extract (POE) in the case of staphylococcal lung colonization/infections characteristic for cystic fibrosis (CF), was examined in vitro. The impact of POE phenolic-rich fraction on the virulence att...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-03-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/24/6/1151 |
id |
doaj-a96588feb58b429d82d034af4477f173 |
---|---|
record_format |
Article |
spelling |
doaj-a96588feb58b429d82d034af4477f1732020-11-25T01:05:22ZengMDPI AGMolecules1420-30492019-03-01246115110.3390/molecules24061151molecules24061151The <i>Pros</i> and <i>Cons</i> of Cystic Fibrosis (CF) Patient Use of Herbal Supplements Containing <i>Pulmonaria officinalis</i> L. Extract: the Evidence from an In Vitro Study on <i>Staphylococcus aureus</i> CF Clinical IsolatesBeata Sadowska0Urszula Wójcik1Justyna Krzyżanowska-Kowalczyk2Mariusz Kowalczyk3Anna Stochmal4Joanna Rywaniak5Julia Burzyńska6Barbara Różalska7Department of Immunology and Infectious Biology, Institute of Microbiology, Biotechnology and Immunology, Faculty of Biology and Environmental Protection, University of Lodz, Banacha 12/16, 90-237 Lodz, PolandDepartment of Immunology and Infectious Biology, Institute of Microbiology, Biotechnology and Immunology, Faculty of Biology and Environmental Protection, University of Lodz, Banacha 12/16, 90-237 Lodz, PolandDepartment of Biochemistry, Institute of Soil Science and Plant Cultivation, State Research Institute, Czartoryskich 8, 24-100 Pulawy, PolandDepartment of Biochemistry, Institute of Soil Science and Plant Cultivation, State Research Institute, Czartoryskich 8, 24-100 Pulawy, PolandDepartment of Biochemistry, Institute of Soil Science and Plant Cultivation, State Research Institute, Czartoryskich 8, 24-100 Pulawy, PolandDepartment of Immunology and Infectious Biology, Institute of Microbiology, Biotechnology and Immunology, Faculty of Biology and Environmental Protection, University of Lodz, Banacha 12/16, 90-237 Lodz, PolandDepartment of Immunology and Infectious Biology, Institute of Microbiology, Biotechnology and Immunology, Faculty of Biology and Environmental Protection, University of Lodz, Banacha 12/16, 90-237 Lodz, PolandDepartment of Immunology and Infectious Biology, Institute of Microbiology, Biotechnology and Immunology, Faculty of Biology and Environmental Protection, University of Lodz, Banacha 12/16, 90-237 Lodz, PolandThe justification for the use of herbal supplements with <i>Pulmonaria officinalis</i> L. extract (POE) in the case of staphylococcal lung colonization/infections characteristic for cystic fibrosis (CF), was examined in vitro. The impact of POE phenolic-rich fraction on the virulence attributes of CF-associated <i>Staphylococcus aureus</i> (<i>S. aureus</i>) clinical strains has been assessed, including pathogen adhesion, biofilm formation on native and protein-conditioned surfaces (mucin, elastin), mature biofilm eradication, staphylococcal protein A expression, α-toxin release, and <i>S. a.</i> adhesion to A549 cells. Cytotoxicity of the extract to lung epithelial cells was also investigated. It was found that POE has bacteriostatic effects at MIC 1–2 mg/mL, recognized as of limited efficacy, but at MIC/subMICs it targeted virulence not viability. It usually decreased <i>S. aureus</i> adhesion and less frequently inhibited biofilm formation on native and protein-conditioned surfaces. Observed effect seems to be related to significant reduction by POE of sortase A activity. However, in some cases POE favored the creation of biofilm by staphylococci and <i>S. aureus</i> adhesion to the lung epithelium was not limited. On the other side POE caused significant decrease of <i>S. a.</i> α-toxin synthesis and slightly weakened the expression of SpA. When used at supraMICs POE eradicated mature biofilm, but in some cases with unsatisfying outcomes. Promisingly, POE has been recognized as a safe product, with no cytotoxicity up to 4 mg/mL. These results reflect the positive, negative or neutral anti-staphylococcal properties of POE. It seems that POE may be beneficial as a prophylactic, but not as a therapeutic or supportive agent in the area of CF—integrative medicine. However, introduction the official recommendations needs further in vivo studies.https://www.mdpi.com/1420-3049/24/6/1151lungwort fractionated phenolic extractcystic fibrosis<i>Staphylococcus aureus</i>adhesionbiofilmcytotoxicity |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Beata Sadowska Urszula Wójcik Justyna Krzyżanowska-Kowalczyk Mariusz Kowalczyk Anna Stochmal Joanna Rywaniak Julia Burzyńska Barbara Różalska |
spellingShingle |
Beata Sadowska Urszula Wójcik Justyna Krzyżanowska-Kowalczyk Mariusz Kowalczyk Anna Stochmal Joanna Rywaniak Julia Burzyńska Barbara Różalska The <i>Pros</i> and <i>Cons</i> of Cystic Fibrosis (CF) Patient Use of Herbal Supplements Containing <i>Pulmonaria officinalis</i> L. Extract: the Evidence from an In Vitro Study on <i>Staphylococcus aureus</i> CF Clinical Isolates Molecules lungwort fractionated phenolic extract cystic fibrosis <i>Staphylococcus aureus</i> adhesion biofilm cytotoxicity |
author_facet |
Beata Sadowska Urszula Wójcik Justyna Krzyżanowska-Kowalczyk Mariusz Kowalczyk Anna Stochmal Joanna Rywaniak Julia Burzyńska Barbara Różalska |
author_sort |
Beata Sadowska |
title |
The <i>Pros</i> and <i>Cons</i> of Cystic Fibrosis (CF) Patient Use of Herbal Supplements Containing <i>Pulmonaria officinalis</i> L. Extract: the Evidence from an In Vitro Study on <i>Staphylococcus aureus</i> CF Clinical Isolates |
title_short |
The <i>Pros</i> and <i>Cons</i> of Cystic Fibrosis (CF) Patient Use of Herbal Supplements Containing <i>Pulmonaria officinalis</i> L. Extract: the Evidence from an In Vitro Study on <i>Staphylococcus aureus</i> CF Clinical Isolates |
title_full |
The <i>Pros</i> and <i>Cons</i> of Cystic Fibrosis (CF) Patient Use of Herbal Supplements Containing <i>Pulmonaria officinalis</i> L. Extract: the Evidence from an In Vitro Study on <i>Staphylococcus aureus</i> CF Clinical Isolates |
title_fullStr |
The <i>Pros</i> and <i>Cons</i> of Cystic Fibrosis (CF) Patient Use of Herbal Supplements Containing <i>Pulmonaria officinalis</i> L. Extract: the Evidence from an In Vitro Study on <i>Staphylococcus aureus</i> CF Clinical Isolates |
title_full_unstemmed |
The <i>Pros</i> and <i>Cons</i> of Cystic Fibrosis (CF) Patient Use of Herbal Supplements Containing <i>Pulmonaria officinalis</i> L. Extract: the Evidence from an In Vitro Study on <i>Staphylococcus aureus</i> CF Clinical Isolates |
title_sort |
<i>pros</i> and <i>cons</i> of cystic fibrosis (cf) patient use of herbal supplements containing <i>pulmonaria officinalis</i> l. extract: the evidence from an in vitro study on <i>staphylococcus aureus</i> cf clinical isolates |
publisher |
MDPI AG |
series |
Molecules |
issn |
1420-3049 |
publishDate |
2019-03-01 |
description |
The justification for the use of herbal supplements with <i>Pulmonaria officinalis</i> L. extract (POE) in the case of staphylococcal lung colonization/infections characteristic for cystic fibrosis (CF), was examined in vitro. The impact of POE phenolic-rich fraction on the virulence attributes of CF-associated <i>Staphylococcus aureus</i> (<i>S. aureus</i>) clinical strains has been assessed, including pathogen adhesion, biofilm formation on native and protein-conditioned surfaces (mucin, elastin), mature biofilm eradication, staphylococcal protein A expression, α-toxin release, and <i>S. a.</i> adhesion to A549 cells. Cytotoxicity of the extract to lung epithelial cells was also investigated. It was found that POE has bacteriostatic effects at MIC 1–2 mg/mL, recognized as of limited efficacy, but at MIC/subMICs it targeted virulence not viability. It usually decreased <i>S. aureus</i> adhesion and less frequently inhibited biofilm formation on native and protein-conditioned surfaces. Observed effect seems to be related to significant reduction by POE of sortase A activity. However, in some cases POE favored the creation of biofilm by staphylococci and <i>S. aureus</i> adhesion to the lung epithelium was not limited. On the other side POE caused significant decrease of <i>S. a.</i> α-toxin synthesis and slightly weakened the expression of SpA. When used at supraMICs POE eradicated mature biofilm, but in some cases with unsatisfying outcomes. Promisingly, POE has been recognized as a safe product, with no cytotoxicity up to 4 mg/mL. These results reflect the positive, negative or neutral anti-staphylococcal properties of POE. It seems that POE may be beneficial as a prophylactic, but not as a therapeutic or supportive agent in the area of CF—integrative medicine. However, introduction the official recommendations needs further in vivo studies. |
topic |
lungwort fractionated phenolic extract cystic fibrosis <i>Staphylococcus aureus</i> adhesion biofilm cytotoxicity |
url |
https://www.mdpi.com/1420-3049/24/6/1151 |
work_keys_str_mv |
AT beatasadowska theiprosiandiconsiofcysticfibrosiscfpatientuseofherbalsupplementscontainingipulmonariaofficinalisilextracttheevidencefromaninvitrostudyonistaphylococcusaureusicfclinicalisolates AT urszulawojcik theiprosiandiconsiofcysticfibrosiscfpatientuseofherbalsupplementscontainingipulmonariaofficinalisilextracttheevidencefromaninvitrostudyonistaphylococcusaureusicfclinicalisolates AT justynakrzyzanowskakowalczyk theiprosiandiconsiofcysticfibrosiscfpatientuseofherbalsupplementscontainingipulmonariaofficinalisilextracttheevidencefromaninvitrostudyonistaphylococcusaureusicfclinicalisolates AT mariuszkowalczyk theiprosiandiconsiofcysticfibrosiscfpatientuseofherbalsupplementscontainingipulmonariaofficinalisilextracttheevidencefromaninvitrostudyonistaphylococcusaureusicfclinicalisolates AT annastochmal theiprosiandiconsiofcysticfibrosiscfpatientuseofherbalsupplementscontainingipulmonariaofficinalisilextracttheevidencefromaninvitrostudyonistaphylococcusaureusicfclinicalisolates AT joannarywaniak theiprosiandiconsiofcysticfibrosiscfpatientuseofherbalsupplementscontainingipulmonariaofficinalisilextracttheevidencefromaninvitrostudyonistaphylococcusaureusicfclinicalisolates AT juliaburzynska theiprosiandiconsiofcysticfibrosiscfpatientuseofherbalsupplementscontainingipulmonariaofficinalisilextracttheevidencefromaninvitrostudyonistaphylococcusaureusicfclinicalisolates AT barbararozalska theiprosiandiconsiofcysticfibrosiscfpatientuseofherbalsupplementscontainingipulmonariaofficinalisilextracttheevidencefromaninvitrostudyonistaphylococcusaureusicfclinicalisolates AT beatasadowska iprosiandiconsiofcysticfibrosiscfpatientuseofherbalsupplementscontainingipulmonariaofficinalisilextracttheevidencefromaninvitrostudyonistaphylococcusaureusicfclinicalisolates AT urszulawojcik iprosiandiconsiofcysticfibrosiscfpatientuseofherbalsupplementscontainingipulmonariaofficinalisilextracttheevidencefromaninvitrostudyonistaphylococcusaureusicfclinicalisolates AT justynakrzyzanowskakowalczyk iprosiandiconsiofcysticfibrosiscfpatientuseofherbalsupplementscontainingipulmonariaofficinalisilextracttheevidencefromaninvitrostudyonistaphylococcusaureusicfclinicalisolates AT mariuszkowalczyk iprosiandiconsiofcysticfibrosiscfpatientuseofherbalsupplementscontainingipulmonariaofficinalisilextracttheevidencefromaninvitrostudyonistaphylococcusaureusicfclinicalisolates AT annastochmal iprosiandiconsiofcysticfibrosiscfpatientuseofherbalsupplementscontainingipulmonariaofficinalisilextracttheevidencefromaninvitrostudyonistaphylococcusaureusicfclinicalisolates AT joannarywaniak iprosiandiconsiofcysticfibrosiscfpatientuseofherbalsupplementscontainingipulmonariaofficinalisilextracttheevidencefromaninvitrostudyonistaphylococcusaureusicfclinicalisolates AT juliaburzynska iprosiandiconsiofcysticfibrosiscfpatientuseofherbalsupplementscontainingipulmonariaofficinalisilextracttheevidencefromaninvitrostudyonistaphylococcusaureusicfclinicalisolates AT barbararozalska iprosiandiconsiofcysticfibrosiscfpatientuseofherbalsupplementscontainingipulmonariaofficinalisilextracttheevidencefromaninvitrostudyonistaphylococcusaureusicfclinicalisolates |
_version_ |
1725194823315488768 |